Stock Events

PHARMANUTRA 

€47.8
3
-€0.4-0.83% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
610.93M
P/E Ratio
38.89
Dividend Yield
1.78%
Dividend
0.85

Upcoming

Dividends

1.78%Dividend Yield
10Y Growth
N/A
5Y Growth
15.14%
3Y Growth
8.26%
1Y Growth
6.25%

Earnings

13MayConfirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2023
Q1 2024
0.22
0.97
1.72
2.47
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PHN.MI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company's products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. The company was founded in 2003 and is based in Pisa, Italy.
Show more...
CEO
Mr. Andrea Lacorte
Employees
86
Country
Italy
ISIN
IT0005274094
WKN
000A2DU6N

Listings